European Commission approves extension of the indication for Doptelet as treatment of ITP Jan. 21, 2021
Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present factor XIa inhibitors Jan. 20, 2021
EdiGene obtains IND approval in China for ET-01 for transfusion dependent beta-thalassemia Jan. 18, 2021
Promising data presented from global phase III study with valoctocogene roxaparvovec in hemophilia A Jan. 12, 2021
RSS